PDCD1 and neoplasm: Multiple pathways were commonly upregulated upon the inhibition of PD-1, PD-L1, or TIM-3, associated with the MAPK signaling pathway, cell differentiation, cell apoptosis, cytolysis, tumor suppression, cell cycle arrest and anti-angiogenesis,.